Credit Suisse’s Radius Health, Inc. RDUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-40,902
| Closed | -$424K | – | 4532 |
|
|
2022
Q2 | $424K | Sell |
40,902
-10,704
| -21% | -$79.6K | ﹤0.01% | 2952 |
|
|
2022
Q1 | $455K | Sell |
51,606
-5,671
| -10% | -$43K | ﹤0.01% | 3029 |
|
|
2021
Q4 | $396K | Sell |
57,277
-15,043
| -21% | -$221K | ﹤0.01% | 3986 |
|
|
2021
Q3 | $897K | Buy |
72,320
+113
| +0.2% | +$1.63K | ﹤0.01% | 3428 |
|
|
2021
Q2 | $1.32M | Buy |
72,207
+1,879
| +3% | +$37.4K | ﹤0.01% | 3177 |
|
|
2021
Q1 | $1.47M | Sell |
70,328
-45,123
| -39% | -$951K | ﹤0.01% | 3050 |
|
|
2020
Q4 | $2.06M | Buy |
115,451
+615
| +0.5% | +$9.23K | ﹤0.01% | 2795 |
|
|
2020
Q3 | $1.3M | Sell |
114,836
-29,147
| -20% | -$360K | ﹤0.01% | 2741 |
|
|
2020
Q2 | $1.96M | Buy |
143,983
+40,483
| +39% | +$557K | ﹤0.01% | 2401 |
|
|
2020
Q1 | $1.35M | Sell |
103,500
-6,085
| -6% | -$108K | ﹤0.01% | 2415 |
|
|
2019
Q4 | $2.21M | Buy |
109,585
+59,423
| +118% | +$1.44M | ﹤0.01% | 2526 |
|
|
2019
Q3 | $1.29M | Buy |
50,162
+10,632
| +27% | +$261K | ﹤0.01% | 2815 |
|
|
2019
Q2 | $964K | Sell |
39,530
-3,531
| -8% | -$77.2K | ﹤0.01% | 2958 |
|
|
2019
Q1 | $858K | Sell |
43,061
-24,754
| -37% | -$452K | ﹤0.01% | 3004 |
|
|
2018
Q4 | $1.12M | Sell |
67,815
-6,395
| -9% | -$108K | ﹤0.01% | 2688 |
|
|
2018
Q3 | $1.32M | Buy |
74,210
+30,200
| +69% | +$683K | ﹤0.01% | 2665 |
|
|
2018
Q2 | $1.3M | Buy |
44,010
+1,280
| +3% | +$40.4K | ﹤0.01% | 2809 |
|
|
2018
Q1 | $1.53M | Buy |
42,730
+5,587
| +15% | +$202K | ﹤0.01% | 2633 |
|
|
2017
Q4 | $1.18M | Sell |
37,143
-21,974
| -37% | -$690K | ﹤0.01% | 2876 |
|
|
2017
Q3 | $2.28M | Buy |
59,117
+6,262
| +12% | +$246K | ﹤0.01% | 2434 |
|
|
2017
Q2 | $2.39M | Sell |
52,855
-39,325
| -43% | -$1.5M | ﹤0.01% | 2118 |
|
|
2017
Q1 | $3.56M | Buy |
92,180
+54,844
| +147% | +$2.3M | ﹤0.01% | 1895 |
|
|
2016
Q4 | $1.42M | Sell |
37,336
-99,666
| -73% | -$4.74M | ﹤0.01% | 2719 |
|
|
2016
Q3 | $7.41M | Buy |
137,002
+7,751
| +6% | +$394K | 0.01% | 1377 |
|
|
2016
Q2 | $4.75M | Sell |
129,251
-34,174
| -21% | -$1.21M | 0.01% | 1664 |
|
|
2016
Q1 | $5.14M | Buy |
163,425
+59,019
| +57% | +$2.04M | 0.01% | 1511 |
|
|
2015
Q4 | $6.42M | Sell |
104,406
-29,412
| -22% | -$1.86M | 0.01% | 1411 |
|
|
2015
Q3 | $9.28M | Buy |
133,818
+37,975
| +40% | +$2.64M | 0.01% | 1160 |
|
|
2015
Q2 | $6.49M | Buy |
95,843
+59,410
| +163% | +$2.77M | 0.01% | 1539 |
|
|
2015
Q1 | $1.5M | Buy |
36,433
+14,975
| +70% | +$673K | ﹤0.01% | 2642 |
|
|
2014
Q4 | $835K | Buy |
+21,458
| New | +$509K | ﹤0.01% | 3298 |
|
Other funds holding RDUS
Credit Suisse's RDUS Position: Q3 2022 in Review
Credit Suisse sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 40,902 shares — an estimated $424K sold.
Credit Suisse first reported a position in RDUS in Q4 2014 and held it in 31 quarters. The position peaked at $9.28M in Q3 2015. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.
- Credit Suisse reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
- Credit Suisse sold 40,902 Radius Health, Inc. shares in Q3 2022, an estimated $424K.
- Credit Suisse first reported a position in Radius Health, Inc. in Q4 2014 and held it in 31 quarters.
- Credit Suisse's Radius Health, Inc. position peaked at $9.28M in Q3 2015.
- 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.
Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.